Selected research
Industry Research
Kidney Transplant Medicine Industry Research Report 2026
Market perspective
The global Kidney Transplant Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Kidney Transplant Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Kidney Transplant Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Kidney Transplant Medicine include Sanofi, Novartis, Pfizer, GlaxoSmithKline plc, Veloxis Pharmaceuticals, Roche Pharmaceuticals, Prometheus Laboratories, Mayne Pharma Group Limited and Hansa Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Kidney Transplant Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Kidney Transplant Medicine Market by Company
Sanofi
Novartis
Pfizer
GlaxoSmithKline plc
Veloxis Pharmaceuticals
Roche Pharmaceuticals
Prometheus Laboratories
Mayne Pharma Group Limited
Hansa Biopharma
BHARAT SERUM
Astellas Pharma
Kidney Transplant Medicine Segment by Type
Tacrolimus
Mycophenolate
Azathioprine
Ciclosporin
Other
Kidney Transplant Medicine Segment by Application
Online Sales
Offline Sales
Kidney Transplant Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Kidney Transplant Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Kidney Transplant Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Kidney Transplant Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tacrolimus
- Mycophenolate
- Azathioprine
- Ciclosporin
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Sanofi
- Novartis
- Pfizer
- GlaxoSmithKline plc
- Veloxis Pharmaceuticals
- Roche Pharmaceuticals
- Prometheus Laboratories
- Mayne Pharma Group Limited
- Hansa Biopharma
- BHARAT SERUM
- Astellas Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Kidney Transplant Medicine Market Size (2021-2032)
- 2.2.2 Global Kidney Transplant Medicine Sales (2021-2032)
- 2.2.3 Global Kidney Transplant Medicine Market Average Price (2021-2032)
- 2.3 Kidney Transplant Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tacrolimus
- 2.3.3 Mycophenolate
- 2.3.4 Azathioprine
- 2.3.5 Ciclosporin
- 2.3.6 Other
- 2.4 Kidney Transplant Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Kidney Transplant Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Kidney Transplant Medicine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Kidney Transplant Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Kidney Transplant Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Kidney Transplant Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Kidney Transplant Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Kidney Transplant Medicine, Product Type & Application
- 3.8 Global Manufacturers of Kidney Transplant Medicine, Established Date
- 3.9 Global Kidney Transplant Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Kidney Transplant Medicine Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Kidney Transplant Medicine Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Kidney Transplant Medicine Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline plc
- 4.4.1 GlaxoSmithKline plc Company Information
- 4.4.2 GlaxoSmithKline plc Business Overview
- 4.4.3 GlaxoSmithKline plc Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio
- 4.4.5 GlaxoSmithKline plc Recent Developments
- 4.5 Veloxis Pharmaceuticals
- 4.5.1 Veloxis Pharmaceuticals Company Information
- 4.5.2 Veloxis Pharmaceuticals Business Overview
- 4.5.3 Veloxis Pharmaceuticals Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio
- 4.5.5 Veloxis Pharmaceuticals Recent Developments
- 4.6 Roche Pharmaceuticals
- 4.6.1 Roche Pharmaceuticals Company Information
- 4.6.2 Roche Pharmaceuticals Business Overview
- 4.6.3 Roche Pharmaceuticals Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio
- 4.6.5 Roche Pharmaceuticals Recent Developments
- 4.7 Prometheus Laboratories
- 4.7.1 Prometheus Laboratories Company Information
- 4.7.2 Prometheus Laboratories Business Overview
- 4.7.3 Prometheus Laboratories Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prometheus Laboratories Kidney Transplant Medicine Product Portfolio
- 4.7.5 Prometheus Laboratories Recent Developments
- 4.8 Mayne Pharma Group Limited
- 4.8.1 Mayne Pharma Group Limited Company Information
- 4.8.2 Mayne Pharma Group Limited Business Overview
- 4.8.3 Mayne Pharma Group Limited Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio
- 4.8.5 Mayne Pharma Group Limited Recent Developments
- 4.9 Hansa Biopharma
- 4.9.1 Hansa Biopharma Company Information
- 4.9.2 Hansa Biopharma Business Overview
- 4.9.3 Hansa Biopharma Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hansa Biopharma Kidney Transplant Medicine Product Portfolio
- 4.9.5 Hansa Biopharma Recent Developments
- 4.10 BHARAT SERUM
- 4.10.1 BHARAT SERUM Company Information
- 4.10.2 BHARAT SERUM Business Overview
- 4.10.3 BHARAT SERUM Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BHARAT SERUM Kidney Transplant Medicine Product Portfolio
- 4.10.5 BHARAT SERUM Recent Developments
- 4.11 Astellas Pharma
- 4.11.1 Astellas Pharma Company Information
- 4.11.2 Astellas Pharma Business Overview
- 4.11.3 Astellas Pharma Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Astellas Pharma Kidney Transplant Medicine Product Portfolio
- 4.11.5 Astellas Pharma Recent Developments
5 Global Kidney Transplant Medicine Market Scenario by Region
- 5.1 Global Kidney Transplant Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Kidney Transplant Medicine Sales by Region: 2021-2032
- 5.2.1 Global Kidney Transplant Medicine Sales by Region: 2021-2026
- 5.2.2 Global Kidney Transplant Medicine Sales by Region: 2027-2032
- 5.3 Global Kidney Transplant Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Kidney Transplant Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Kidney Transplant Medicine Revenue by Region: 2027-2032
- 5.4 North America Kidney Transplant Medicine Market Facts & Figures by Country
- 5.4.1 North America Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Kidney Transplant Medicine Sales by Country (2021-2032)
- 5.4.3 North America Kidney Transplant Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Kidney Transplant Medicine Market Facts & Figures by Country
- 5.5.1 Europe Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Kidney Transplant Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Kidney Transplant Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Kidney Transplant Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Kidney Transplant Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Kidney Transplant Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Kidney Transplant Medicine Market Facts & Figures by Country
- 5.7.1 South America Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Kidney Transplant Medicine Sales by Country (2021-2032)
- 5.7.3 South America Kidney Transplant Medicine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Kidney Transplant Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Kidney Transplant Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Kidney Transplant Medicine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Kidney Transplant Medicine Sales by Type (2021-2032)
- 6.1.1 Global Kidney Transplant Medicine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Kidney Transplant Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Kidney Transplant Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Kidney Transplant Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Kidney Transplant Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Kidney Transplant Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Kidney Transplant Medicine Sales by Application (2021-2032)
- 7.1.1 Global Kidney Transplant Medicine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Kidney Transplant Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Kidney Transplant Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Kidney Transplant Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Kidney Transplant Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Kidney Transplant Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Kidney Transplant Medicine Value Chain Analysis
- 8.1.1 Kidney Transplant Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Kidney Transplant Medicine Production Mode & Process
- 8.2 Kidney Transplant Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Kidney Transplant Medicine Distributors
- 8.2.3 Kidney Transplant Medicine Customers
9 Global Kidney Transplant Medicine Analyzing Market Dynamics
- 9.1 Kidney Transplant Medicine Industry Trends
- 9.2 Kidney Transplant Medicine Industry Drivers
- 9.3 Kidney Transplant Medicine Industry Opportunities and Challenges
- 9.4 Kidney Transplant Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst